ATXI Valuation

Avenue Therapeutics Inc

Add to Watchlist

Advanced Chart

0.415

-0.005(-1.190%)1D

Overview
Forecast
Valuation
Earnings

ATXI Relative Valuation

ATXI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ATXI is overvalued; if below, it's undervalued.

Historical Valuation

Avenue Therapeutics Inc (ATXI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.71. The fair price of Avenue Therapeutics Inc (ATXI) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.41

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.52

P/B

Median3y

-8.68

Median5y

-0.77

-700.97

FCF Yield

Median3y

-211.71

Median5y

-128.68

Competitors Valuation Multiple

The average P/S ratio for ATXI's competitors is 0.00, providing a benchmark for relative valuation. Avenue Therapeutics Inc Corp (ATXI) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ATXI.O

Avenue Therapeutics Inc

Loss

Average P/S: 0.00

3.37M